Stryker to acquire SERF SAS, enhancing its global joint replacement leadership

Medical technology firm Stryker on Monday said it executed a binding offer to Menix to acquire SERF SAS, a France-based joint replacement company.

SERF SAS develops, manufactures and sells a range of large joint replacement products on an international basis.

Mahwah-based Stryker believes the acquisition complements its existing presence in France, and in Europe as well. It also believes SERF SAS bolsters its global joint replacement portfolio, allowing it to serve a wider range of patients.

Since its founding, which dates back more than 50 years, the company developed a number of “innovative concepts,” Mahwah-based Stryker said. This includes inventing the original Dual Mobility Cup for hip replacement, according to a news release.

In accordance with French law, the execution of any binding agreement would occur after the works council information-consultation process has been completed.

The proposed acquisition is expected to close during the first quarter of 2024, subject to customary closing conditions, including regulatory approvals.

SERF SAS has its main office in Décines-Charpieu, France.